Therapeutic management of in-stent thrombosis after thoracic endovascular aortic repair for blunt thoracic aortic injury in a coronavirus disease 2019 patient.
Karen van RijnAbbey SchepersRutger W van der MeerCarla S P van RijswijkJan van SchaikJoost R van der VorstPublished in: Journal of vascular surgery cases and innovative techniques (2023)
A 27-year-old man underwent thoracic endovascular aortic repair for blunt thoracic aortic injury. Fourteen months later, he presented with intermittent paraplegia, congestive heart failure, and a decline of kidney function as a result of high-grade aortic stenosis caused by in-stent thrombosis. He had a concurrent infection with coronavirus disease 2019. The patient was successfully treated using axillofemoral bypass, followed by stent relining 2 weeks later. The possible risk factors and the optimal therapeutic approach for in-stent thrombosis remain unknown, because only a limited number of cases describing this rare complication have been reported.
Keyphrases
- coronavirus disease
- aortic valve
- aortic stenosis
- spinal cord
- left ventricular
- pulmonary embolism
- heart failure
- high grade
- risk factors
- transcatheter aortic valve replacement
- aortic valve replacement
- case report
- ejection fraction
- transcatheter aortic valve implantation
- low grade
- trauma patients
- spinal cord injury
- squamous cell carcinoma
- radiation therapy
- locally advanced
- atrial fibrillation
- coronary artery
- rectal cancer